
    
      This is randomized two-arm parallel controlled open label study that will be conducted at two
      sites, in Slovenia and Israel. It is an investigator initiated pediatric clinical study.

      Study will be conducted on pediatric population during two weeks, following a 3 day Run-in
      period that will allow the patients to get familiar with study device and CGM (SmartGuard
      OFF).

      Patients will be asked to continuously wear the study device for 14 days, which will be set
      up by study staff according to randomization in the specific group. They will be provided
      with a diary for entering their daily activity, food consumption (carb count) and eventual
      adverse events.
    
  